Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses

Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses

US Patent 7220420 · Granted May 22, 2007

Estimated economic value: $3,376,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus2010
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus2008
Electrical choke2007
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus2005
Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus2003
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus2001
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus1999
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus1998
Peptides for inducing cytotoxic T lymphocyte responses hepatitis B virus1998
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus1998
Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte re1998
Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte re1998